Ozempic generated A$21 billion of sales in 2023 alone. So how was it developed? And how are its new competitors, Mounjaro and Zepbound, different?
Academic rigor, journalistic flair
Articles on Eli Lilly
Displaying all articles
Trust in brands may be eroded as awareness of misinformation increases according to new research.
Anti-obesity medications are becoming the go-to treatment for weight loss. But drugs alone may not provide the same benefits as lifestyle choices like exercise and a healthy diet.
The drugmaker’s move responded to the growing competition that has shaken up the insulin market in recent years.
Although Medicare has agreed to pay for Aduhelm, its coverage comes with restrictions.
Monoclonal antibodies are synthetic molecules manufactured in the lab. But do we need them if a vaccine is on its way?
Top contributors
-
Dean of the Sol Price School of Public Policy; Distinguished Professor of Pharmacy, Public Policy, and Economics, University of Southern California
-
ARC Future Fellow, School of Biomedical Sciences, The University of Queensland
-
Regents' Professor & Chair, Medical Laboratory Science, Texas State University
-
Assistant Professor of Emergency Medicine, Albert Einstein College of Medicine
-
Professor of Exercise Science and Interim Dean of the School of Health Sciences, College of Charleston
-
Executive Director of the Value of Life Sciences Innovation program; Fellow at the USC Schaeffer Center, University of Southern California
-
Lecturer in Marketing & Strategy, Cardiff University
